Fischer Medical Ventures Appoints Chan Sing En to Subsidiary Board
Fischer Medical Ventures Ltd 路 Others (Uncategorized) 路 27 Oct 2026, 8:23 pm
Fischer Medical Ventures Appoints Chan Sing En to Subsidiary Board Fischer Medical Ventures Limited has appointed Mr. Chan Sing En as an Independent Director on the Board of FMV Global Innovations Pte. Ltd., Singapore, an unlisted material wholly owned subsidiary, effective 27th Oct'26. Mr. Chan brings over three decades of experience in private equity, corporate finance, capital raising, and operational turnarounds across Southeast Asia and Australia. He currently serves as Principal and Director at SovCapital Pte Ltd and sits on the advisory board of FTAG Investment Bank, holding no relations to existing company directors.
Original exchange filing (PDF)
More announcements from Fischer Medical Ventures Ltd
- Financial results for the quarter and half year ended 30th Sept 2026 路 15 Nov 2026
- Outcome of Board Meeting held on 14th Nov 2026 for approval of Q2 financials 路 15 Nov 2026
- Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- The Monitoring Agency Report for the quarter ended 30 September 2026 is enclosed. 路 14 Nov 2026
- Fischer Medical Ventures Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
- Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve the unaudited standalone .... 路 14 Nov 2026
- Postal Ballot Notice & Scrutinizer 路 14 Oct 2026
